소마젠

950200KOSDAQ

64.3 / 100

Reference Date: 2026-09-08

Financial Score19.0 / 40

News Sentiment21.3 / 25

Momentum14.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Surged 15.1% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

SomaGen provides diverse genomic analysis services, including NGS, CES, single-cell analysis, and proteomics, collaborating with institutions like the US NIH and global pharmaceutical companies through a B2B model, establishing a strong presence in the North American market. It also expands into the B2C sector with DTC genetic testing and microbiome analysis services, leveraging partnerships with companies such as 10x Genomics and Olink Proteomics to enhance its technological capabilities.

Number of Employees

88people

Average Salary

78.6M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 15.004.0Point

PBR

—Industry Average 1.203.5Point

ROE

-15.09Industry Average 8.000.0Point

Well below industry avg

Debt Ratio

33.35Industry Average 100.006.5Point

Half of industry avg (excellent)

Trend 2023~20255.0 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲29.7% (2-year basis)

Operating Profit Growth Rate

2.0 / 3

Avg ▲8.9% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -15.9% (declining, 3yr)

Detailed News Sentiment

4 totalPositive 4Neutral 0Negative 0Average Sentiment Score 85

Positive
소마젠, '장기 고객' 모더나 암백신 성과에 주목…"제약사 매출 증가....
소마젠의 장기 고객 모더나 암백신 성공으로 인해 제약사 매출 증가 기대.
Positive
"암도 잡는다" 모더나 177% 폭등...국내 mRNA주도 '들썩'
소마젠 주가 상승은 모더나의 긍정적 임상 결과로 인한 국내 mRNA 관련 주식 시장의 활성화에 따른 것이다.
Positive
소마젠, 2026년 상반기 턴어라운드 성공... 재무구조 대폭 개선
소마젠이 상반기 흑자 전환과 재무구조 개선으로 긍정적인 성과를 보여주며 투자자들에게 기대감을 제공했다.

Detailed Momentum

52-week position5.0Point

52w mid range (52%)

Current 3,310Won52-week high 4,12552-week low 2,410

1-month return6.0Point

1m +15.13% (strong rise)

Volume trend3.0Point

Volume flat

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral반기보고서 (2026.06)2026-08-14